- Krokodil (desomorphine)
- Levamisole-adulterated cocaine
- Methamphetamine-induced allergic reaction
- Wound botulism secondary to heroin use
Pain management in the ED has become a balancing act. EPs must continually balance adequate pain management with the risks of opioids prescribing. As providers reach into their pain management toolbox it is always nice to have as many options as possible because one size does not fit all. Specifically for the management of acute renal colic, IV preservative-free (cardiac) lidocaine has been gaining popularity as a potential alternative when opioids are unable to get job done or are contraindicated due to co-morbidities or a history of addiction. Is it safe? Does it work?
Calcium channel blocker overdose can produce a deadly toxidrome that requires rapid recognition and intervention. Dr. Joshua C. Feblowitz, a PGY-3 EM resident at the Harvard-Affiliated Emergency Medicine Residency at Brigham and Women’s Hospital and Massachusetts General Hospital, created a high-yield infographic on the symptoms and management of this important toxidrome!
We are proud to present Capsules Module 10: Concepts in Infectious Disease, now published on ALiEMU. Here is a summary of the key points from a stellar module by Drs. Meghan Groth and Paul Takamoto. When you’re finished, head over to the Capsules page for even more practical pharmacology for the EM provider.
Welcome to the 4th annual installment of our must-know Emergency Medicine pharmacotherapy articles post, this time for 2017. We summarize some important EM pharmacotherapy articles from the last 12 months. We have tried to focus on articles that you may have missed, but are potentially high-impact for improving clinical practice in the ED. Without further ado, we present the 12 must-know EM pharmacotherapy articles of 2017.
The 2016 American Headache Society (AHS) released recommendations on managing adults with acute migraine headaches.1 In the November 2017 EM:RAP LIN Sessions podcast episode that I recorded, I realized that I overgeneralized several statements about anti-dopaminergic agents and the use of concurrent diphenhydramine for akathisia risk reduction. So I wanted to clarify things and share a deeper-dive on the topic, thanks to the constructive feedback and help of headache guru Dr. David Vinson and EM pharmacists Dr. Curtis Geier, Dr. Bryan Hayes, and Dr. Zlatan Coralic. Below summarizes the nuanced thought processes in the anti-dopaminergic treatment of migraines.